N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use
US6117901A · kind A · utility
4Cited by
3References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 21, 1997 |
| Grant date | Sep 12, 2000 |
| Priority date | — |
| Expiry date | Nov 21, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/277
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit .beta.-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits .beta.-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.